Journal of Molecular and Cellular Cardiology
Volume 49, Issue 4 , Pages 587-597 , October 2010

Chronic AMD3100 antagonism of SDF-1α–CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction

  • Shujing Dai

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • These authors contributed equally.
    • ,
  • Fangping Yuan

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • These authors contributed equally.
    • ,
  • Jingyao Mu

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • ,
  • Chengxin Li

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • ,
  • Ning Chen

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • ,
  • Shangzhi Guo

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • ,
  • Justin Kingery

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • ,
  • Sumanth D. Prabhu

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • Louisville Veterans Affairs Medical Center, Louisville, KY, USA
    • ,
  • Roberto Bolli

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • ,
  • Gregg Rokosh

      Affiliations

    • Institute of Molecular Cardiology, University of Louisville, Louisville, KY, USA
    • Corresponding Author InformationCorresponding author. Institute of Molecular Cardiology, 570 South Preston Street, University of Louisville, Louisville, KY 40202, USA. Tel.: +1 502 852 2459; fax: +1 502 852 2494.

Received 1 January 2010 ,Revised 13 July 2010 ,Accepted 13 July 2010.

References 

  1. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. Aug 2004;10(8):858–864
  2. Christopherson KW, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol. Dec 15 2002;169(12):7000–7008
  3. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. Mar 2004;35(3):233–245
  4. Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, et al. Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation. Aug 7 2007;116(6):654–663
  5. Pyo RT, Sui J, Dhume A, Palomeque J, Blaxall BC, Diaz G, et al. CXCR4 modulates contractility in adult cardiac myocytes. J Mol Cell Cardiol. Nov 2006;41(5):834–844
  6. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. Jun 11 1998;393(6685):595–599
  7. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. Nov 23 2004;110(21):3300–3305
  8. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet. Aug 30 2003;362(9385):697–703
  9. Segers VF, Tokunou T, Higgins LJ, MacGillivray C, Gannon J, Lee RT. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction. Circulation. Oct 9 2007;116(15):1683–1692
  10. Zaruba MM, Theiss HD, Vallaster M, Mehl U, Brunner S, David R, et al. Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction. Cell Stem Cell. Apr 3 2009;4(4):313–323
  11. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny. Immunity. Aug 2003;19(2):257–267
  12. Christopherson KW, Cooper S, Broxmeyer HE. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells. Blood. Jun 15 2003;101(12):4680–4686
  13. Anderlini P, Przepiorka D, Seong D, Miller P, Sundberg J, Lichtiger B, et al. Clinical toxicity and laboratory effects of granulocyte-colony-stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures. Transfusion. Jul 1996;36(7):590–595
  14. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. Apr 18 2005;201(8):1307–1318
  15. Liles WC, Rodger E, Broxmeyer HE, Dehner C, Badel K, Calandra G, et al. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist. Transfusion. Mar 2005;45(3):295–300
  16. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ, et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med. Jan 1998;4(1):72–77
  17. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. Aug 15 1996;382(6592):635–638
  18. Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. Aug 2005;115(8):2108–2118
  19. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med. Apr 17 1997;336(16):1131–1141
  20. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. Dec 21–28 1995;378(6559):785–789
  21. Wang QM, Fiol CJ, DePaoli-Roach AA, Roach PJ. Glycogen synthase kinase-3 beta is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem. May 20 1994;269(20):14566–14574
  22. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. Nov 15 1998;12(22):3499–3511
  23. Alt JR, Cleveland JL, Hannink M, Diehl JA. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. Dec 15 2000;14(24):3102–3114
  24. Liao Y, Wei Y, Zhou X, Yang JY, Dai C, Chen YJ, et al. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation. Oncogene. Jul 2 2009;28(26):2436–2445
  25. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. Sep 19 2003;114(6):763–776
  26. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD, et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med. Aug 2007;13(8):970–974
  27. Cho J, Rameshwar P, Sadoshima J. Distinct roles of GSK-3{alpha} and GSK-3{beta} in mediating cardiomyocyte differentiation in murine bone marrow derived mesenchymal stem cells. J Biol Chem. Oct 26 2009;
  28. Kerkela R, Kockeritz L, Macaulay K, Zhou J, Doble BW, Beahm C, et al. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. J Clin Invest. Nov 2008;118(11):3609–3618
  29. Luo D, Renault VM, Rando TA. The regulation of Notch signaling in muscle stem cell activation and postnatal myogenesis. Semin Cell Dev Biol. Aug–Oct 2005;16(4–5):612–622
  30. Berdnik D, Torok T, Gonzalez-Gaitan M, Knoblich JA. The endocytic protein alpha-Adaptin is required for numb-mediated asymmetric cell division in Drosophila. Dev Cell. Aug 2002;3(2):221–231
  31. Guo Y, Hangoc G, Bian H, Pelus LM, Broxmeyer HE. SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells. Stem Cells. Oct 2005;23(9):1324–1332
  32. Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM, et al. Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation. Apr 29 2008;117(17):2224–2231
  33. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. Jun 2004;113(11):1535–1549
  34. Matsuda T, Zhai P, Maejima Y, Hong C, Gao S, Tian B, et al. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload. Proc Natl Acad Sci U S A. Dec 30 2008;105(52):20900–20905
  35. Skyschally A, van Caster P, Boengler K, Gres P, Musiolik J, Schilawa D, et al. Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res. Jan 2 2009;104(1):15–18
  36. Proulx C, El-Helou V, Gosselin H, Clement R, Gillis MA, Villeneuve L, et al. Antagonism of stromal cell-derived factor-1alpha reduces infarct size and improves ventricular function after myocardial infarction. Pflugers Arch. Nov 2007;455(2):241–250
  37. Dawn B, Guo Y, Rezazadeh A, Huang Y, Stein AB, Hunt G, et al. Postinfarct cytokine therapy regenerates cardiac tissue and improves left ventricular function. Circ Res. Apr 28 2006;98(8):1098–1105
  38. Altarche-Xifro W, Curato C, Kaschina E, Grzesiak A, Slavic S, Dong J, et al. Cardiac c-kit+AT2+ cell population is increased in response to ischemic injury and supports cardiomyocyte performance. Stem Cells. Oct 2009;27(10):2488–2497
  39. Nie Y, Han YC, Zou YR. CXCR4 is required for the quiescence of primitive hematopoietic cells. J Exp Med. Apr 14 2008;205(4):777–783
  40. Chen M, Xie HQ, Deng L, Li XQ, Wang Y, Zhi W, et al. Stromal cell-derived factor-1 promotes bone marrow-derived cells differentiation to cardiomyocyte phenotypes in vitro. Cell Prolif. Apr 2008;41(2):336–347
  41. Larrea MD, Liang J, Da Silva T, Hong F, Shao SH, Han K, et al. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4. Mol Cell Biol. Oct 2008;28(20):6462–6472
  42. Okumura E, Fukuhara T, Yoshida H, Hanada Si S, Kozutsumi R, Mori M, et al. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat Cell Biol. Feb 2002;4(2):111–116
  43. Katayama K, Fujita N, Tsuruo T. Akt/protein kinase B-dependent phosphorylation and inactivation of WEE1Hu promote cell cycle progression at G2/M transition. Mol Cell Biol. Jul 2005;25(13):5725–5737
  44. Li Y, Dowbenko D, Lasky LA. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem. Mar 29 2002;277(13):11352–11361

PII: S0022-2828(10)00274-9

doi: 10.1016/j.yjmcc.2010.07.010

Journal of Molecular and Cellular Cardiology
Volume 49, Issue 4 , Pages 587-597 , October 2010

Article Tools

* Image Usage & Resolution